Acute Myeloid Leukemia Cebpa Gene Mutation Cn305571
A blood cancer affecting blood-forming tissue in the bone marrow where white blood cells grow abnormally. Most common in older adults. Treatment includes chemotherapy and sometimes stem cell transplant.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Severe headache
Fatigue
(hematologic)Easy bruising
(hematologic)Frequent infections
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Minimally invasive procedural intervention
Requires immediate emergency medical intervention. Do not delay treatment.
Standard Induction Chemotherapy
7+3 cytarabine and anthracycline-based induction therapy targeting rapid blast reduction in monoallelic CEBPA AML, followed by risk-adapted consolidation strategies.
Allogeneic Stem Cell Transplant
Considered in first remission for patients with additional risk factors given intermediate prognosis of monoallelic CEBPA mutations, providing potential curative graft-versus-leukemia effect.
Additional treatment options
FLT3 Inhibitor Adjunctive Therapy
If concurrent FLT3 mutations present, add FLT3 inhibitors to standard chemotherapy to improve response rates and outcomes in this molecularly complex disease.
medicationResponse-Adapted Monitoring Protocol
Tailored monitoring frequency based on initial treatment response, with intensified surveillance for patients showing suboptimal molecular responses requiring treatment modification.
monitoringIntegrative Medicine Support
Incorporation of evidence-based complementary therapies including acupuncture for symptom management and mind-body practices to support conventional treatment tolerance and recovery.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Acute Myeloid Leukemia Cebpa Gene Mutation Cn305571?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424-447.
Wouters BJ, Löwenberg B, Delwel R. A decade of genome-wide gene expression profiling in acute myeloid leukemia: "The double hit" concept and emerging concepts of intraclonal heterogeneity. Blood. 2015;126(5):589-596.
Green CL, Koo KK, Hills RK, Evans CM, Webb DK, Burnett AK, et al. Prognostic significance of CEBPA mutations in younger patients with acute myeloid leukemia: A combined analysis of the United Kingdom Medical Research Council and Dutch-Belgian Hemato-Oncology Cooperative Groups. J Clin Oncol. 2012;30(24):2989-2997.
Liu Q, Wang RH, Liu D, Zhao CX, Wang WJ, Zhao X, et al. NPM1 and CEBPA mutations in acute myeloid leukemia: A systematic review and meta-analysis. Medicine (Baltimore). 2020;99(28):e21234.
Medication Comparisons
Compare medications used to treat Acute Myeloid Leukemia Cebpa Gene Mutation Cn305571. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy